Top Markets
Coin of the day
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Rangering i aksjer #32096
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Aksjekurs
$0.21483059
Sist synkronisert: 2024-05-07
Markedsverdi
$11.13M
Endring (1 dag)
0.34%
Endring (1 år)
0.00%
Land
CA
Handel Antibe Therapeutics Inc. (ATE)

Kategori

Historikk for aksjesplitt for Antibe Therapeutics Inc. (ATE)
Aksjen Antibe Therapeutics Inc. (symbol: ATE) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 18, 2026.
Én ATE-aksje kjøpt før Aug 18, 2026 tilsvarer i dag 0 ATE-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
3 x12
US